Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT4/LT3 combination therapy versus LT4 alone for persistent tiredness in autoimmune hypothyroidism
NL-OMON54941Phase 3Recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of levothyroxine sodium and liothyronine in autoimmune thyroiditis and hypothyroidism (2 arms), sponsored by Erasmus MC. Started Oct 2022; status: recruiting.
02
Drugs
levothyroxine sodiumliothyronine
03
Conditions
autoimmune thyroiditishypothyroidism
Beyond the preview
Go deeper on NL-OMON54941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54941.